In the September 29, 2014, Federal Register, FDA announced it was reopening the comment period for the draft guidances titled Internet/Social Media Platforms with Character Space Limitations: Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices (Federal Register) and Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices (Federal Register), in response to a request for additional time. Comments due October 29, 2014.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.